- Report
- February 2024
- 122 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- September 2022
- 83 Pages
Global
From €3185EUR$3,500USD£2,731GBP
- Report
- May 2022
- 37 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2022
- 50 Pages
Global
From €2275EUR$2,500USD£1,951GBP
Prostaglandin E2 (PGE2) is a hormone-like substance that is used in the treatment of sexual and reproductive health issues. It is used to induce labor, treat menstrual cramps, and reduce the risk of miscarriage. It is also used to treat infertility, endometriosis, and other gynecological conditions. PGE2 is available in various forms, including tablets, injections, and suppositories.
PGE2 is a widely used drug in the sexual and reproductive health market. It is used to treat a variety of conditions, and its effectiveness has been demonstrated in numerous clinical trials. It is also relatively safe and has few side effects.
Companies in the PGE2 market include Pfizer, Merck, Novartis, and Bayer. These companies produce a variety of PGE2 products, including tablets, injections, and suppositories. Other companies, such as Teva Pharmaceuticals and Mylan, also produce generic versions of PGE2. Show Less Read more